Varicose veins are a common medical condition where the veins, typically in the legs, become enlarged and twisted, causing discomfort and aesthetic concerns for many individuals. While lifestyle changes and conservative measures like compression stockings can provide relief to some extent, advanced treatment options involving medical devices have gained prominence.
Medtronic (US) Acquired Veniti Medical, Inc. (US) in August 2023, strengthening its varicose vein treatment portfolio with Veniti's ClosureFast™ radiofrequency ablation system.
Boston Scientific (US) Received FDA approval for its next-generation Spectraneural® Symphony™ radiofrequency ablation catheter in July 2023, featuring improved tip design and temperature control for enhanced treatment efficacy.
Merit Medical Systems, Inc. (US) Launched its SealSure™ Closure System in June 2023, a novel venous closure device offering a simplified and efficient approach to treating smaller varicose veins.
Stellite Medical (US) Developed the Mobi-Cath™ System, a portable radiofrequency ablation system designed for use in outpatient settings, aiming to increase patient access to minimally invasive varicose vein treatment.
Poly Medicure Ltd. (India) Announced plans to expand its manufacturing capacity for varicose vein treatment devices to meet the growing demand in emerging markets, particularly in Asia.
AngioDynamics
Medtronic
Teleflex Incorporated
Sciton, Inc.
Dornier Medtech
Merit Medical Systems
Alma Lasers
Biolitec AG
Boston Scientific Corporation
Varicose Veins Treatment Devices Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)